Bradley Hyman

Um, the other collaborators, so we have two main collaborators.

One was, um, from Brad Hyman's group at MGH, um, where we obtained some Alzheimer's patient brain tissue-

Mm-hmm

... 'cause he runs, uh, the Alzheimer's Center there, and they've got really well-characterized, uh, pathology, um, you know, tissue that you can use.

...

in terms of what the data says.

And we actually, we had obtained, um, this human tau plasmid in, in a viral vector, this AAV vector from Brad Hyman's group, um, to see initially in the knockout, can we observe transmission of tau or is there a deficit-

Hmm